Mimetas

About:

MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.

Twitter/X: mimetas_3d

Top Investors: Korys, EASME - EU Executive Agency for SMEs, PMV, OostNL, InnovationQuarter

Description:

MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.

Total Funding Amount:

$32.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Leiden, Zuid-Holland, The Netherlands

Founded Date:

2013-01-01

Contact Email:

info(AT)mimetas.com

Founders:

Jos Joore, Paul Vulto, Thomas Hankemeier

Number of Employees:

101-250

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries: